Background Atrio-ventricular (AV) block is a common bradyarrhythmia in the elderly, but is a rare event in young or middle-aged adults, often leading to pacemaker implantation without further investigation, though underlying aetiology influences both treatment strategies and prognosis. Cardiovascular magnetic resonance (CMR) has the potential to identify an underlying aetiology for AV block, over and above transthoracic echocardiogram (TTE), which is offered as the first imaging technique. We sought to assess the diagnostic additive role of CMR in young and middle aged adults (18-60 years) with high-grade AV block and to determine which findings on CMR best predict clinical impact.
Methods
We retrospectively analysed the CMR registry from a tertiary centre in the South-West of England to collect data on consecutive high-grade AV block patients (18-60 yrs) referred for CMR between September 2012 to July 2015. High-grade AVB was defined as the evidence of Mobitz II 2 nd degree or complete AVB on resting electrocardiogram (ECG). Patients underwent TTE and a comprehensive CMR protocol (including long and short axis cines, and late gadolinium enhancement, LGE, imaging). A change in diagnosis was defined as CMR findings leading to a new diagnosis compared to a multi-parametric pre-CMR diagnosis (clinical data, ECG and TTE).
Results
We identified 31 patients with AV block (17 male, 55%) with a mean age of 43 ± 11 years (IQR 33-53 years). CMR was diagnostic in all but 2 patients (7%): an ischemic heart disease was found in 3 (10%) patients, non-ischemic heart disease in 11 (35%), of which 3 had infiltrative cardiomyopathy, and a structurally normal heart in 15 (48%). As compared to pre-CMR diagnosis, CMR findings led to a change in diagnosis in 45% of patients. In a multivariate model adjusting for demographic and CMR characteristics, only LGE was a significant independent predictor of the underlying diagnosis (p 0.4, 95% CI 1.07-62.1) ( Table 1) .
Conclusions
Management of AVB in young is challenging. Our study highlights that CMR can lead to a new diagnosis in almost half of patients. LGE was the only significant Bristol NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute, Bristol, UK 
